{
  "paper_id": "PMC7240664",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240664/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Flow diagram of the subjects' recruitment in this study. All the subjects were divided into the atropine use group and the control group who had never used atropine (n = 106 : 103).",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f2/7240664/5c6461be23c2/JOPH2020-4919154.001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f2/7240664/5c6461be23c2/JOPH2020-4919154.001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f2/7240664/5c6461be23c2/JOPH2020-4919154.001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f2/7240664/5c6461be23c2/JOPH2020-4919154.001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f2/7240664/5c6461be23c2/JOPH2020-4919154.001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC7240664/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f2/7240664/5c6461be23c2/JOPH2020-4919154.001.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Participants were divided into two groups: 106 in the atropine group and 103 in the nonatropine group (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "M = spherical equivalent, J180 = J180 astigmatism; J45 = J45 astigmatism.Figure 2.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Figure 2 shows the relative peripheral refractions (RPR) of emmetropes in the atropine and the nonatropine group.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In Figure 2, the relative peripheral refractions of spherical equivalent (M) in the atropine group showed more myopia in the nasal field or temporal field.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "For astigmatism J45, the atropine group showed more relative peripheral myopia at 10° of the temporal and at 10°, 20°, and 30° of the nasal field compared to the nonatropine group, but there were no statistically significant differences (see Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "For J45, the atropine group showed more relative peripheral myopia at 20° and 30° of the temporal field and 30° of the nasal field compared to the nonatropine group; a significant difference was observed at 30° of the temporal field (t = 2.84, df = 36, P=0.01) (see Figure 4).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 1,
    "claims_count": 65,
    "images_downloaded": 1,
    "tables_filtered": 264
  }
}